Therapeutic Effect of Chemotherapy Azacytidine Plus CAOLD Regimen on Patients With Relapsed/Refractory Peripheral T-Cell Lymphomas

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT06176027

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:27:10.535461+00:00

Published At

2024-10-29T00:00:00+00:00

Record Updated At

2024-10-29

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Relapsed Peripheral T-Cell Lymphomas", "Refractory Peripheral T-Cell Lymphomas"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2024-10-29"

protocolSection.identificationModule.nctId

"NCT06176027"

protocolSection.identificationModule.officialTitle

"Therapeutic Effect of Chemotherapy Azacytidine Plus CAOLD Regimen on Patients With Relapsed/Refractory Peripheral T-Cell Lymphomas"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["PHASE1", "PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Relapsed Peripheral T-Cell Lymphomas (protocolSection.conditionsModule.conditions)
• Refractory Peripheral T-Cell Lymphomas (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.